Cubist Systematic Strategies, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$15.16 - $23.26 $27,500 - $42,193	-1,814 Reduced 99.94%	1 $0
Q1 2023 May 15, 2023	SELL	$15.45 - $23.19 $221,197 - $332,011	-14,317 Reduced 88.75%	1,815 $31,000
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $110,504 - $410,720	16,132 New	16,132 $358,000
Q2 2022 Aug 15, 2022	BUY	$5.68 - $15.99 $133,866 - $376,852	23,568 New	23,568 $165,000
Q1 2022 May 16, 2022	SELL	$13.16 - $22.64 $235,735 - $405,550	-17,913 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $350,378 - $590,054	17,913 New	17,913 $393,000

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $666M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.